These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 29465743)

  • 1. Participation in bowel screening among men attending abdominal aortic aneurysm screening.
    Quyn AJ; Fraser CG; Rodger J; Digan A; Anderson AS; Steele RJC
    Br J Surg; 2018 Apr; 105(5):529-534. PubMed ID: 29465743
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Attitudes towards the Faecal Occult Blood Test (FOBT) versus the Faecal Immunochemical Test (FIT) for colorectal cancer screening: perceived ease of completion and disgust.
    Chambers JA; Callander AS; Grangeret R; O'Carroll RE
    BMC Cancer; 2016 Feb; 16():96. PubMed ID: 26872450
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tailored telephone counselling to increase participation of underusers in a population-based colorectal cancer-screening programme with faecal occult blood test: A randomized controlled trial.
    Denis B; Broc G; Sauleau EA; Gendre I; Gana K; Perrin P
    Rev Epidemiol Sante Publique; 2017 Feb; 65(1):17-28. PubMed ID: 28089385
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Direct mailing of faecal occult blood tests for colorectal cancer screening: a randomized population study from Central Italy.
    Giorgi Rossi P; Grazzini G; Anti M; Baiocchi D; Barca A; Bellardini P; Brezzi S; Camilloni L; Falini P; Maccallini V; Mantellini P; Romeo D; Rubeca T; Venditti MA
    J Med Screen; 2011; 18(3):121-7. PubMed ID: 22045820
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early detection of colorectal cancer with faecal occult blood test screening.
    Paimela H; Malila N; Palva T; Hakulinen T; Vertio H; Järvinen H
    Br J Surg; 2010 Oct; 97(10):1567-71. PubMed ID: 20603855
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of faecal occult blood test screening on emergency admissions and short-term outcomes for colorectal cancer.
    Libby G; Brewster DH; Steele RJ
    Br J Surg; 2014 Nov; 101(12):1607-15. PubMed ID: 25219923
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Faecal occult blood testing (FOBT)-based colorectal cancer screening trends and predictors of non-use: findings from the South Australian setting and implications for increasing FOBT uptake.
    Todorov K; Wilson C; Sharplin G; Corsini N
    Aust Health Rev; 2018 Feb; 42(1):45-52. PubMed ID: 28248632
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomised controlled trial of personalised decision support delivered via the internet for bowel cancer screening with a faecal occult blood test: the effects of tailoring of messages according to social cognitive variables on participation.
    Wilson CJ; Flight IH; Turnbull D; Gregory T; Cole SR; Young GP; Zajac IT
    BMC Med Inform Decis Mak; 2015 Apr; 15():25. PubMed ID: 25886492
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluating the effectiveness of GP endorsement on increasing participation in the NHS Bowel Cancer Screening Programme in England: study protocol for a randomized controlled trial.
    Damery S; Smith S; Clements A; Holder R; Nichols L; Draper H; Clifford S; Parker L; Hobbs R; Wilson S
    Trials; 2012 Feb; 13():18. PubMed ID: 22348399
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors influencing participation in colorectal cancer screening programs in Spain.
    Vanaclocha-Espi M; Ibáñez J; Molina-Barceló A; Pérez E; Nolasco A; Font R; Pérez-Riquelme F; de la Vega M; Arana-Arri E; Oceja M; Espinàs JA; Portillo I; Salas D;
    Prev Med; 2017 Dec; 105():190-196. PubMed ID: 28887191
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is screening for abdominal aortic aneurysm acceptable to the population? Selection and recruitment to hospital-based mass screening for abdominal aortic aneurysm.
    Lindholt JS; Juul S; Henneberg EW; Fasting H
    J Public Health Med; 1998 Jun; 20(2):211-7. PubMed ID: 9675742
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Faecal occult blood test-based screening programme with high compliance for colonoscopy has a strong clinical impact on colorectal cancer.
    Parente F; Marino B; DeVecchi N; Moretti R; ; Ucci G; Tricomi P; Armellino A; Redaelli L; Bargiggia S; Cristofori E; Masala E; Tortorella F; Gattinoni A; Odinolfi F; Pirola ME
    Br J Surg; 2009 May; 96(5):533-40. PubMed ID: 19358181
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of rurality, deprivation and distance from clinic on uptake in men invited for abdominal aortic aneurysm screening.
    Crilly MA; Mundie A; Bachoo P; Nimmo F
    Br J Surg; 2015 Jul; 102(8):916-23. PubMed ID: 25955478
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Understanding of a negative bowel screening result and potential impact on future symptom appraisal and help-seeking behaviour: a focus group study.
    Barnett KN; Weller D; Smith S; Orbell S; Vedsted P; Steele RJC; Melia JW; Moss SM; Patnick J; Campbell C
    Health Expect; 2017 Aug; 20(4):584-592. PubMed ID: 27414462
    [TBL] [Abstract][Full Text] [Related]  

  • 15. What influences the decision to participate in colorectal cancer screening with faecal occult blood testing and sigmoidoscopy?
    van Dam L; Korfage IJ; Kuipers EJ; Hol L; van Roon AH; Reijerink JC; van Ballegooijen M; van Leerdam ME
    Eur J Cancer; 2013 Jul; 49(10):2321-30. PubMed ID: 23571149
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Results of National Colorectal Cancer Screening Program in Croatia (2007-2011).
    Katičić M; Antoljak N; Kujundžić M; Stamenić V; Skoko Poljak D; Kramarić D; Stimac D; Strnad Pešikan M; Samija M; Ebling Z
    World J Gastroenterol; 2012 Aug; 18(32):4300-7. PubMed ID: 22969192
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ultrasound screening for abdominal aortic aneurysm in high-risk women.
    Duncan A; Maslen C; Gibson C; Hartshorne T; Farooqi A; Saratzis A; Bown MJ
    Br J Surg; 2021 Oct; 108(10):1192-1198. PubMed ID: 34370826
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trends and inequities in colorectal cancer screening participation in Ontario, Canada, 2005-2011.
    Honein-AbouHaidar GN; Baxter NN; Moineddin R; Urbach DR; Rabeneck L; Bierman AS
    Cancer Epidemiol; 2013 Dec; 37(6):946-56. PubMed ID: 23702337
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ontario's ColonCancerCheck: results from canada's first province-wide colorectal cancer screening program.
    Rabeneck L; Tinmouth JM; Paszat LF; Baxter NN; Marrett LD; Ruco A; Lewis N; Gao J
    Cancer Epidemiol Biomarkers Prev; 2014 Mar; 23(3):508-15. PubMed ID: 24443406
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Participation rates for organized colorectal cancer screening programmes: an international comparison.
    Klabunde C; Blom J; Bulliard JL; Garcia M; Hagoel L; Mai V; Patnick J; Rozjabek H; Senore C; Törnberg S
    J Med Screen; 2015 Sep; 22(3):119-26. PubMed ID: 25967088
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.